Advances in Management of Acute Promyelocytic Leukemia with Arsenic Trioxide

被引：0
|
作者：
马军 [1 ]
机构：
[1] Harbin Institute of Hematology & Oncology Harbin150010
来源：
Chinese Journal of Integrative Medicine | 2007年 / 02期
关键词：
ATRA; Advances in Management of Acute Promyelocytic Leukemia with Arsenic Trioxide;
D O I：
暂无
中图分类号：
R733.71 [急性白血病];
学科分类号：
100214 ;
摘要：
Acute promyelocytic leukemia (APL), with specific features in cell morphology, is classified as M3
引用
收藏
页码：92 / 94
页数：3
相关论文
共 50 条
  • [31] Visual Hallucinations With Arsenic Trioxide Therapy in Acute Promyelocytic Leukemia
    Mahadevia, Himil J.
    Al-Obaidi, Ammar
    Cossor, Furha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [32] Pharmacokinetics of arsenic trioxide in patients with acute promyelocytic leukemia.
    Nagy, AJ
    Wang, ZG
    Maslak, P
    Chanel, S
    Ho, R
    Spriggs, D
    Tong, W
    Ellison, R
    Pandolfi, PP
    Warrell, RP
    Soignet, SL
    JOURNAL OF INVESTIGATIVE MEDICINE, 1999, 47 (02) : 100A - 100A
  • [33] Arsenic trioxide for acute promyelocytic leukemia in a patient on chronic hemodialysis
    Tinajero, Jose
    El-Shami, Khaled
    Wu, Xiaojun
    Smith, B. Douglas
    Newman, Matthew J.
    LEUKEMIA RESEARCH REPORTS, 2022, 17
  • [34] Pharmacokinetics of intravenous arsenic trioxide in the treatment of acute promyelocytic leukemia
    Ni, JH
    Chen, GQ
    Shen, ZX
    Li, XS
    Liu, HW
    Huang, YT
    Fang, ZW
    Chen, SJK
    Wang, ZY
    Chen, Z
    CHINESE MEDICAL JOURNAL, 1998, 111 (12) : 1107 - 1110
  • [35] Arsenic trioxide:: a "successful poison" in patients with acute promyelocytic leukemia
    Lengfelder, E.
    Schultheis, B.
    Buechner, T.
    Hehlmann, R.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2007, 132 (07) : 330 - 336
  • [36] Clinical usefulness of arsenic trioxide in the treatment of acute promyelocytic leukemia
    Lo Coco, F
    HAEMATOLOGICA, 2002, 87 (05) : 452 - 453
  • [37] METABOLIC CHARACTERIZATION OF ACUTE PROMYELOCYTIC LEUKEMIA AND ARSENIC TRIOXIDE RESISTANCE
    Noguera, N. I.
    Banella, C.
    Catalano, G.
    Ammatuna, E.
    Pelosi, E.
    Faraoni, I.
    Divona, M.
    Otone, T.
    Lavorgna, S.
    Testa, U.
    Arcese, W.
    Voso, M. T.
    HAEMATOLOGICA, 2020, 105 : S84 - S84
  • [38] Summary report on the treatment of acute promyelocytic leukemia with arsenic trioxide
    Jin, H
    Li, XQ
    Li, HY
    METAL IONS IN BIOLOGY AND MEDICINE, VOL 8, 2004, 8 : 543 - 547
  • [39] The pharmacokinetics of therapeutic arsenic trioxide in acute promyelocytic leukemia patients
    Ghiuzeli, Cristina M.
    Styblo, Miroslav
    Saunders, Jesse
    Calabro, Anthony
    Budman, Daniel
    Allen, Steven
    Devoe, Craig
    Dhingra, Radhika
    LEUKEMIA & LYMPHOMA, 2022, 63 (03) : 653 - 663
  • [40] Treatment of Relapsed Acute Promyelocytic Leukemia by Arsenic Trioxide in Iran
    Alimoghaddam, Kamran
    Ghavamzadeh, Ardeshir
    Jahani, Mohamad
    Mousavi, Asadolah
    Iravani, Masoud
    Rostami, Shahrbano
    Ghaffari, Hamidolah
    Hosseini, Roholah
    Jalili, Mehdi
    ARCHIVES OF IRANIAN MEDICINE, 2011, 14 (03) : 167 - 169
12345